Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 59,337,727
- Total 13F value
- $655,471,603
- Share change
- -1,321,897
- Put/Call ratio
- 856%
- SEC-reported price per share
- $11.05
- Number of holders
- 109
- Value change
- -$7,845,717
- Number of buys
- 64
- Number of sells
- 49
- Shares outstanding
- 51,428,000
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q4 2021
Institutions
109
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAUPOST GROUP LLC/MA
Disclosed value leader
BAUPOST GROUP LLC/MA
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 27%
Showing 1-6 of 15 holder rows.
Quick read
BAUPOST GROUP LLC/MA leads the comparable SEC ownership view at 27%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BAUPOST GROUP LLC/MA
27%
ORBIMED ADVISORS LLC
11%
VANGUARD GROUP INC
11%
BlackRock Finance, Inc.
9.9%
Madison Avenue Partners, LP
9.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAUPOST GROUP LLC/MA |
13F
Company
|
27%
|
$101,085,000
13,660,168 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
11%
|
$43,624,000
5,895,159 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
11%
|
$43,339,000
5,856,555 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
9.9%
|
$37,772,000
5,104,459 shares
|
— | 30 Sep 2021 |
| Madison Avenue Partners, LP |
13F
Company
|
9.6%
|
$36,478,000
4,929,423 shares
|
— | 30 Sep 2021 |
| Point72 Asset Management, L.P. |
13F
Company
|
6.6%
|
$25,201,000
3,405,602 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
109
Shares
59,337,727
Rows available
109
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
111
Q4 2021 holders
109
Holder diff
-2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend